Venatorx Pharmaceuticals Announces Organizational Changes

By WebmasterDecember 20, 2022November 1st, 2024No Comments

Venatorx Pharmaceuticals Announces Organizational Changes

Chief Medical Officer Timothy Henkel, M.D., Ph.D., Retires

Vincent Milano Steps Down from Board of Directors

Previous PostPalvella Therapeutics Announces Series D Financing of Up to $37.7 Million to Accelerate Late-Stage Development and Support Commercialization of Novel Therapies for Serious, Rare Genetic Skin Diseases
Next PostSenzo Secures Additional $1.9MM Equity Funding for Its PCR-Accurate Lateral Flow Test